Pharmacologic stress cardiovascular magnetic resonance in the pediatric population: A review of the literature, proposed protocol, and two examples in patients with Kawasaki disease.

Autor: Fares M; Division of Pediatric Cardiology, UH Rainbow Babies & Children's Hospital, Cleveland, Ohio., Critser PJ; Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Arruda MJ; Division of Pediatric Cardiology, UH Rainbow Babies & Children's Hospital, Cleveland, Ohio., Wilhelm CM; Division of Pediatric Cardiology, UH Rainbow Babies & Children's Hospital, Cleveland, Ohio., Rattan MS; Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Lang SM; Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio., Alsaied T; Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
Jazyk: angličtina
Zdroj: Congenital heart disease [Congenit Heart Dis] 2019 Nov; Vol. 14 (6), pp. 1166-1175. Date of Electronic Publication: 2019 Sep 09.
DOI: 10.1111/chd.12840
Abstrakt: Pharmacologic stress cardiovascular magnetic resonance (PSCMR) is a well-established and reliable diagnostic tool for evaluation of coronary artery disease in the adult population. Stress imaging overall and PSCMR in particular is less utilized in the pediatric population with limited reported data. In this review, we highlight the potential use of PSCMR in specific pediatric cohorts with congenital and acquired heart disease, and we review the reported experience. A suggested protocol is presented in addition to two case examples of patients with Kawasaki disease where PSCMR aided decision making.
(© 2019 Wiley Periodicals, Inc.)
Databáze: MEDLINE
Externí odkaz: